JSC "Grindeks" informs that it has received Statement of "Grindeks" Vice-chairman of the Council Vitālijs Gavrilovs on his resignation from the position of the Member of Council. The Council in the new composition will be approved in the next shareholders' meeting. Notification on the Annual General Meeting of Shareholders of JSC "Grindeks" will be published shortly. On “Grindeks” “Grindeks” is the leading pharmaceutical company in the Baltic States. Its main fields of action are: research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients. “Grindeks” specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. Group consists of four subsidiary companies in Latvia, Estonia and Russia, as well representatives and representative offices in fourteen countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are: the Baltic States, Russia and other CIS countries, Japan, USA. JSC “Grindeks” shares are listed in the Official List of “NASDAQ OMX Riga”. Further information: Laila Kļaviņa Head of the Communications Department JSC “Grindeks” Phones: (+371) 67083370, (+371) 29256012 Fax: (+371) 67083505 e-mail: laila.klavina@grindeks.lv